Profits at Bupa the UK’s most recognised private healthcare provider have surged by nearly a fifth as growing numbers of patients look beyond the NHS due to record waiting times
Profits at Bupa the UK’s most recognised private healthcare provider have surged by nearly a fifth as growing numbers of patients look beyond the NHS due to record waiting times
A new oral medication weight loss, orforglipron, has shown promising results in a landmark trial, marking a significant step for obesity treatment in the UK. Developed by Eli Lilly, orforglipron
Shares in European drug companies slumped to a four-month low on Wednesday, after US President Donald Trump reiterated his intention to impose tariffs on pharmaceutical imports in a bid to
Alzheimers patients can extend cognitive health for years with breakthrough drugs ||| Groundbreaking trial results have revealed that radical new treatments can effectively stall the progression of Alzheimer’s disease for
The impending strike by resident doctors in the NHS is set to take place from 7am on Friday 25 July to 7am on Wednesday 30 July 2025. This strike follows
Assura the NHS landlord at the centre of a lengthy bidding war has reported strong annual results that strengthen shareholder resolve to resist a buyout by private equity. The FTSE
Superbugs could cause a dramatic surge in global deaths and inflict economic losses nearing $2 trillion each year by 2050, new research reveals. Projections from a UK government-backed study, led
In a landmark transaction, US pharmaceutical behemoth Merck has secured the acquisition of London-based Verona Pharma for approximately $10 billion, marking a significant milestone in the biotech sector. The deal
WeightWatchers is embarking on a transformative journey following a significant debt restructuring, positioning itself to compete in the evolving landscape of weight management solutions. The company, which recently emerged from
In a decisive move to streamline healthcare regulation, six NHS safety quangos are set to undergo significant restructuring or complete abolition following revelations of their ineffectiveness despite substantial financial outlays.
The British Medical Association’s impending ballot results for approximately 50,000 resident doctors could trigger significant financial implications for the NHS, with healthcare leaders expressing grave concerns about the economic impact
The Labour government has revealed its comprehensive ten-year strategy for reforming the National Health Service, centring on three pivotal elements: community-based care delivery, service digitalisation, and illness prevention. The announcement,
The Labour government has announced an ambitious £52 billion restructuring of the National Health Service, signalling a fundamental shift from hospital-centred care to community-based treatment facilities. Prime Minister Keir Starmer’s
Sir Pascal Soriot, the chief executive of AstraZeneca, Britain’s most valuable public company, has privately expressed his desire to relocate the pharmaceutical giant’s stock market listing to the United States,
Private healthcare giant Bupa has been ordered to pay £17 million in compensation to Australian members following revelations that the company deliberately blocked legitimate health insurance claims. The Australian Competition
The British government has unveiled a transformative ten-year strategy aimed at revolutionising NHS staffing policies, with UK-trained medical professionals positioned to receive preferential treatment in job allocations. The ambitious plan,






